Biobank Market

Biobank Market Major Players Thermo Fisher Scientific
Inc., BioLife Solutions, Inc., Beckman Coulter, Inc.,
Panasonic Biomedical Sales and Tecan AG.
Biobank is a type of repository which collects and store biological samples for biomedical
research. The human biological materials include blood, purified DNA, saliva, serum, and other
specimens. Preservation of cells and tissues samples is done by cryopreservation at -196 0C or
using chemicals. The biobanks keep a health related records of genetic information, lifestyle,
and family history. Biobank help researchers to detect human diseases and their unspecified
causes by conducting various tests on the samples. Biobanks are largely used to access variety
of data representing a large number of people for providing personalized medications,
minimizing drug reactions, stem cell research, updating age demographic databases. The biorepositories play a fundamental role in research and development, which is associated with drug
development and discovery. Biobanks also provide inevitable assistance in gaining prospective to
orphan diseases associated with genome wide studies via single nucleotide polymorphism (SNP).
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/896
Development of personalized medicine to develop effective therapies drives the global biobank
market
Poor productivity rate of the pharmaceutical industry with 90% failure of proposed drugs during
clinical trials, the adherence of human tissue samples, and stem cells to execute pre-clinical
trials for reducing high cost associated drug failures are the factors expected to drive the
growth of biobank market. Additionally, novelty in cell and tissue disorder treatments, drug
discovery, rising incidence of chronic diseases and government initiatives for innovation of
regenerative medicines are the key factors driving the global biobank market. The extensive
development of personalized treatments by research organizations to develop effective therapies
to satisfy medical needs using biological samples is expected to fuel the demand for biobank
market during the forecast period. For instance, Illumina signed 4 biobank deals in 2016, with
Partners HealthCare, Montreal Heart Institute, University of Colorado and Vanderbilt University
with an objective to improve healthcare and develop personalized medicines. However, cost
competitive techniques, tissue injury during freezing, reimbursement concerns, lack of
standardization, confidentiality and surveillance issues, economic downturn, and ethical issues
are the major factors restraining the growth for global biobank market.
Report includes chapters which deeply display the following deliverable about industry :
• Biobank Market Research Objective and Assumption
• Biobank Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Biobank Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Biobank Market, By Regions
• Biobank Market Competition by Manufacturers including Production, Share, Revenue, Average
Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Biobank Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Biobank Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers
of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Biobank Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Establishment of drug efficacy contributes to the dominance of target tissue segment
The global biobank market is segmented on the basis of bio preservation media types, products,
analysis, applications, end user and geography.
On the basis of bio preservation media types, the global biobank market is segmented into:
• Optimized Pre-Formulated Media
• Non-Optimized Isotonic Formulation Media
On the basis of products, the global biobank market is segmented into:
• Consumables
• Equipment
• Refrigerators and Ice Machines
• Liquid Nitrogen Supply Tanks
• Cryogenic Storage Systems
On the basis of analysis, the global biobank market is segmented into:
• Human tissue and tumor cells
• Bio-fluids
• Stem cells
• Umbilical cord
• DNA/RNA
On the basis of application, the global biobank market is segmented into:
• Biobanking
• Regenerative Medicine
• Drug Discovery
On the basis of end-user, the global biobank market is segmented into:
• Diagnostic Clinical Centers
• Research Organizations
• Others
Ask For Discount Before Purchasing This Business Report @
https://www.coherentmarketinsights.com/insight/request-discount/896
Increasing funds from National Institute of Health, USA is expected to dominate North America
in the global biobank market
Regional segmentation of the global biobank market by Coherent Market Insights comprises
North America, Latin America, Europe, and Asia-Pacific. According to the research conducted
by BioMed Central, United States, stored 270 million specimens in biobanks in 2008, with the
rate of new samples collected being 20 million every year. North America is expected to
dominate the global biobank market with the increasing funds from healthcare organizations
like National Institute of Health (NIH) and National Cancer Institute, which facilitate biobanks
across the U.S. Additionally, the rising interest in biotechology has facilitated collaborations of
biobanks which is expected to augment the global biobank market in the forecast period. AsiaPacific is expected to have an opportunistic biobank market owing to the rise in diseases,
government initiative to finance the cell-based therapies, substantial investment
pharmaceutical, high number of biotechnology companies, and public awareness.
by
Automation of storage processes is the latest trend adopted by the key players
Key players operating the global biobank market includes Thermo Fisher Scientific Inc., BioLife
Solutions, Inc., Beckman Coulter, Inc., Panasonic Biomedical Sales and Tecan AG. New product
launches, increasing collaborations, mergers and acquisitions and partnerships among the market
players are some of the strategies observed in global biobanks market. Biomatrica, IntegenX,
radiofrequency identification, and micro electromechanical systems are the innovative reagents
and products launched for the storage and stabilization of DNA and RNA at room temperature.
The other companies operating in the global biobank market are BioCision, Taylor-Wharton
International, VWR International and So-Low Environmental Equipment Co. among others.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Biobank is a type of repository which collects and store biological samples for biomedical research.

Download Report